SARS-CoV-2 delta variant, a variant of concern (VOC), known as B.1.617.2, was detected in India in October of 2020. However, it rapidly spread all over of the world and now it is the dominant variant in the world, which account for more than 99% of the c
SARS-CoV-2 Spike Delta Variant antibody is supplied in PBS containing 0.02% sodium azide.
Reinheit:
Anti-SARS-CoV-2 Spike Delta Variant antibody is affinity chromatography purified via peptide column.
Target-Kategorie:
It can only detect SARS-CoV-2 Delta Variant (B.1.617.2) Spike S1 protein and does not cross-react with the spike protein of other variants.
Antibody Type:
Polyclonal Antibody
Anwendungsbeschreibung:
WB: 1 µg/mL. Antibody validated: Western Blot in human samples. Anti-SARS-CoV-2 Spike L452R (Delta Variant) antibody specifically detects SARS-CoV-2 Delta Variant (B.1.617.2) Spike S1 protein, but not SARS-CoV-2 WT and other variant Spike S1 proteins
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten